RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Return on equity (%)

RESMED INC【RMD】

Market cap
$37B
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Jun 30, 202525.9+13.92%
Jun 30, 202422.7-5.26%
Jun 30, 202324-4.01%
Jun 30, 202225+41.58%
Jun 30, 202117.6-35.21%
Jun 30, 202027.2+38.90%
Jun 30, 201919.6+24.78%
Jun 30, 201815.7-16.18%
Jun 30, 201718.7-12.76%
Jun 30, 201621.5+1.75%
Jun 30, 201521.1+2.93%
Jun 30, 201420.5+7.39%
Jun 30, 201319.1+25.02%
Jun 30, 201215.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)